Close Window

Digital Look Email A Friend

GSK plans $30bn US investment as pharma faces tariff threat

Published by Frank Prenesti on 17th September 2025

(Sharecast News) - GSK has announced plans to invest $30bn across the US in research and development and supply chain infrastructure over the next five years, amid fears of tariffs being imposed on the pharma industry by US President Donald Trump, who is in the UK on a state visit.

URL: http://www.digitallook.com/dl/news/story/35358764/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.